Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Amgen
AMGN
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$337.38
1.43
0.43%
At Close: -
$337.38
0
0.00%
After Hours: Sep 20, 4:39 PM EDT
15 minutes delayed
Get Report
Comment
Amgen (AMGN) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Amgen (NASDAQ:AMGN) Stock
Amgen Stock (NASDAQ: AMGN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, September 19, 2024
Behind the Scenes of Amgen's Latest Options Trends
Benzinga Insights
Wednesday, September 18, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Wednesday, September 11, 2024
UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
Vandana Singh
Tuesday, September 10, 2024
Terns Stock Soars on Positive Data From Phase I Study of Obesity Drug
Zacks
Monday, September 09, 2024
Amgen Presents New Data For IMDELLTRA In Smal...
Benzinga Newsdesk
Thursday, September 05, 2024
Fake Ozempic Targets Weight-Loss Market: Forged Batches An International Concern
Michael Juliano
Wednesday, September 04, 2024
MHRA Finds No Evidence Supporting Link Betwee...
Benzinga Newsdesk
Amgen CEO Says Look Forward To Obesity Drug T...
Benzinga Newsdesk
Tuesday, September 03, 2024
Despite Medicare Negotiations, Americans May Still Have To Pay More For Prescription Drugs
Vandana Singh
(AMGN) - Analyzing Amgen's Short Interest
Benzinga Insights
Thursday, August 29, 2024
Amgen Unusual Options Activity For August 29
Benzinga Insights
Intuit, Amgen And Sprott Uranium Miners ETF: CNBC's 'Final Trades'
Avi Kapoor
Wednesday, August 28, 2024
CNBC Halftime Report Final Trades: Intuit, Am...
Benzinga Newsdesk
Thursday, August 22, 2024
Moody's Revises Amgen's Outlook To Stable Fro...
Benzinga Newsdesk
Tuesday, August 20, 2024
Amgen Announces Availability Of Otezla In The...
Benzinga Newsdesk
US Stocks May Take A Breather After S&P 500's Impressive 8-Session Winning Streak: Strategist Says Market Will Hit Fresh Highs In Next 4 Weeks, But Warns Investors Of Potential Risks
Shanthi Rexaline
Thursday, August 15, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Monday, August 12, 2024
Smart Money Is Betting Big In AMGN Options
Benzinga Insights
Thursday, August 08, 2024
Amgen Options Trading: A Deep Dive into Market Sentiment
Benzinga Insights
Wednesday, August 07, 2024
TD Cowen Maintains Buy on Amgen, Raises Price...
Benzinga Newsdesk
Amgen's Mixed Q2 Results Highlight Obesity Drug Potential, Analysts Focus Shifts To Upcoming Clinical Readouts
Vandana Singh
Oppenheimer Maintains Outperform on Amgen, Ma...
Benzinga Newsdesk
Deutsche Bank Reiterates Hold on Amgen, Lower...
Benzinga Newsdesk
B of A Securities Maintains Neutral on Amgen,...
Benzinga Newsdesk
Wall Street Poised For Second Day Of Gains While Bank Of Japan Makes Reassurances; Dollar Strengthens Against Yen, Crude Prices Surge: What's Driving Markets Wednesday?
Piero Cingari
RBC Capital Maintains Outperform on Amgen, Ra...
Benzinga Newsdesk
Amgen Faces Near-Term Challenges But Long-Term Growth Prospects Remain Strong: Analyst
Vandana Singh
Wells Fargo Downgrades Amgen to Equal-Weight,...
Benzinga Newsdesk
US Stocks Set To Extend Gains Despite Mixed Earnings, VIX Dips Back Toward Pre-Sell-Off Levels: Analyst Says Pullback Is A 'Growth Scare' And Not 'Calamity'
Shanthi Rexaline
Amgen shares are trading lower after the comp...
Benzinga Newsdesk
Tuesday, August 06, 2024
Amgen Sees FY24 Adj. EPS $19.10-$20.10 vs $17...
Benzinga Newsdesk
Amgen Q2 2024 Adj. EPS $4.97 Misses $5.01 Est...
Benzinga Newsdesk
Wall Street Rebounds After Selloff, VIX Falls, Dollar Surges Against Yen: What's Driving Markets Tuesday?
Piero Cingari
Amgen Gears Up For Q2 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Avi Kapoor
US Stocks Set To Open Higher After Monday's Crash, VIX Plummets: Analyst Says Would Have Worried If Market Surged Higher Without Correction
Shanthi Rexaline
Friday, August 02, 2024
Amgen's Options: A Look at What the Big Money is Thinking
Benzinga Insights
Wednesday, July 31, 2024
Should You Invest in the iShares Biotechnology ETF?
Zacks
Tuesday, July 30, 2024
Bristol Myers, Johnson & Johnson, AbbVie, AstraZeneca Expect Minimal Impact From Upcoming Medicare Price Negotiations
Vandana Singh
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
$100 Invested In This Stock 20 Years Ago Would Be Worth $600 Today
Benzinga Insights
Friday, July 26, 2024
Unpacking the Latest Options Trading Trends in Amgen
Benzinga Insights
Thursday, July 25, 2024
Market Whales and Their Recent Bets on AMGN Options
Benzinga Insights
Friday, July 19, 2024
Amgen Says Currently Assessing Global IT Outa...
Benzinga Newsdesk
Thursday, July 18, 2024
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
Piero Cingari
Tuesday, July 16, 2024
Unpacking the Latest Options Trading Trends in Amgen
Benzinga Insights
Monday, July 15, 2024
A Closer Look at Amgen's Options Market Dynamics
Benzinga Insights
Friday, July 12, 2024
Live On CNBC, Kevin Simpson Announces Bought ...
Benzinga Newsdesk
Thursday, July 11, 2024
Check Out What Whales Are Doing With AMGN
Benzinga Insights
Morgan Stanley Maintains Equal-Weight on Amge...
Benzinga Newsdesk
Wednesday, July 10, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch